Form 4 for EDIT Editas Medicine, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-02 · accession 0001650664-24-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-05 | 2024-03-02 | EDIT | O'Neill Gilmore Neil | CEO, Dir | A - Grant | $0.00 | +275.1K | 260.9K | New | $0 |
| D | 2024-03-05 | 2024-03-05 | EDIT | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $9.42 | -77.8K | 327.5K | -19% | -$733.1K |
| D | 2024-03-05 | 2024-03-02 | EDIT | O'Neill Gilmore Neil | CEO, Dir | A - Grant | $0.00 | +392.1K | 392.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-02 | A | A | 72,212 | $0.00 | 405,294 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-05 | S | D | 77,824 | $9.42 | 327,470 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $9.1036 to $9.4298. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-03-02 | A | A | 72,213 | $0.00 | 333,082 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-02 | A | A | 130,700 | $0.00 | 260,869 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2024-03-02 | A | A | 392,100 | $0.00 | 392,100 | D | $10.53 · — to 2034-03-01 | 392,100 Common Stock | (F6) This option was granted on March 2, 2024 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2024 through March 2, 2028. |